Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Carcinoembryonic antigen (CEA\; MIM 114890) is one of the most widely used tumor markers in serum immunoassay determinations of carcinoma. Additionally we are shipping CEACAM6 Proteins (11) and CEACAM6 Kits (10) and many more products for this protein.
Showing 10 out of 60 products:
Human Monoclonal CEACAM6 Primary Antibody for cELISA, FACS - ABIN108733
Daniel, Nagel, Johnson, Lobo, Hirn, Jantscheff, Kuroki, von Kleist, Grunert: Determination of the specificities of monoclonal antibodies recognizing members of the CEA family using a panel of transfectants. in International journal of cancer. Journal international du cancer 1993
Show all 25 references for ABIN108733
Human Polyclonal CEACAM6 Primary Antibody for IHC, WB - ABIN2776853
Muenzner, Rohde, Kneitz, Hauck: CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells. in The Journal of cell biology 2005
Show all 2 references for ABIN2776853
Human Polyclonal CEACAM6 Primary Antibody for WB - ABIN2776852
Litkouhi, Litkouhi, Fleming, Welch, Berkowitz, Birrer, Mok: Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms. in Gynecologic oncology 2008
show the upregulation of the tumor-associated antigens CEACAM5 (show CEACAM5 Antibodies)/6 by trans-signaling of the pro-inflammatory cytokine IL-6 (show IL6 Antibodies)
Data suggest ways in which carcinoembryonic antigen-related cell adhesion molecules CEACAM6 and CEACAM8 regulate the biological functions of one another.
vaccination with recombinant attenuated Salmonella harboring the CEACAM6 and 4-1BBL (show TNFSF9 Antibodies) gene efficiently increased the number of CD3 (show CD3 Antibodies)+CD8 (show CD8A Antibodies)+ TIL (show TLR1 Antibodies) and NK cells, decreased the number of FOXP3 (show FOXP3 Antibodies) cells and inhibited the development of DMH (show DST Antibodies)-induced colorectal cancer
CEACAM6 increased the levels of phosphorylated AKT (show AKT1 Antibodies), which is involved in the progression of a variety of human tumors.
Data show that carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) and forkhead box P3 (FOXP3 (show FOXP3 Antibodies)) are associated with the malignant degree of pancreatic cancer.
Data indicate that carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes angiogenesis in gastric cancer via focal adhesion kinase FAK signaling.
Results show that pancreatic cancer patients with CEACAM 1 (show CEACAM1 Antibodies), 5 and 6 expression showed a significantly shortened overall survival and elevated serum values are correlated with distant metastasis suggesting a role in epithelial-mesenchymal transition.
CEACAM6 expression was expressed in different molecular subtypes of breast cancer. Among different subtypes, the highest expression was found with HER2 (show ERBB2 Antibodies) positive cancers.
High carcinoembryonic (show CEACAM5 Antibodies) cell adhesion molecule (show MCAM Antibodies) 6 expression is associated with malignant biliary stenoses.
our findings identified CEACAM6, which is regulated by miR (show MLXIP Antibodies)-29a/b/c, as an important positive regulator of EMT (show ITK Antibodies) in pancreatic cancer
Carcinoembryonic antigen (CEA\; MIM 114890) is one of the most widely used tumor markers in serum immunoassay determinations of carcinoma. An apparent lack of absolute cancer specificity for CEA probably results in part from the presence in normal and neoplastic tissues of antigens that share antigenic determinants with the 180-kD form of CEA (Barnett et al., 1988
carcinoembryonic antigen-related cell adhesion molecule 6
, non-specific crossreacting antigen
, normal cross-reacting antigen